Imbruvica Seen to Improve Long-Term Survival in Certain Leukemia Patients, Trial Data Show
News
People with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia (CLL/SLL) who were treated with Imbruvica (ibrutinib) in a clinical trial — and then followed for several years — ... Read more